Bridgewood v. MoonLake Immunotherapeutics
Bridgewood v. MoonLake Immunotherapeutics is a federal securities / commodities lawsuit filed on 10/15/2025 in the District Court, S.D. New York. The case was terminated on 10/22/2025.
- Court
- District Court, S.D. New York (S.D.N.Y.)
Official Court Website → - Assigned judge
- Lewis A. Kaplan · 5,645 cases in index
- Docket number
- 1:25-cv-08500
- Cause
- 15:78m(a) Securities Exchange Act
15 U.S.C. § 78m - Nature of suit
- 850 Securities/Commodities
Alleged violations of federal securities or commodities laws. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 10/15/2025
- Date terminated
- 10/22/2025
13,855 Securities / Commodities cases in this court are indexed here.
Parties
- plaintiff · Bridgewood
- defendant · MoonLake Immunotherapeutics Pharmaceuticals & Biotechnology · 2 cases
Part of a Larger Litigation Pattern
This is one of 3 Securities / Commodities cases in our index naming MoonLake Immunotherapeutics — a possible mass-tort or coordinated-litigation cluster.
About Securities / Commodities Lawsuits
Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
Frequently Asked Questions
What is Bridgewood v. MoonLake Immunotherapeutics?
Bridgewood v. MoonLake Immunotherapeutics is a federal securities / commodities lawsuit filed on 10/15/2025 in the District Court, S.D. New York. The case was terminated on 10/22/2025. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What type of case is this?
It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What court is the case in?
The case is in the District Court, S.D. New York, docket number 1:25-cv-08500.
When was the case filed?
Bridgewood v. MoonLake Immunotherapeutics was filed on 10/15/2025. It was terminated on 10/22/2025.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 78m.
Other Cases Involving These Parties
Related Securities / Commodities Cases
Source: public U.S. federal court record (docket 71653623).